世界のナノ医薬品市場2016

調査会社QYResearch社が発行したリサーチレポート(データ管理コード:QYR61222954)
◆英語タイトル:Global Nanopharmaceuticals Market Research Report 2016
◆発行会社/調査会社:QYResearch
◆商品コード:QYR61222954
◆発行日:2016年9月19日
◆調査対象地域:グローバル
◆産業分野:化学・材料
◆ページ数:124
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single UserUSD2,900 ⇒換算¥327,700見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD5,800 ⇒換算¥655,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界のナノ医薬品市場2016]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

Notes:Production, means the output of Nanopharmaceuticals
Revenue, means the sales value of Nanopharmaceuticals

This report studies Nanopharmaceuticals in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Merck
Pfizer
Novartis
Abbott
GlaxoSmithKline
Roche
Sanofi
Eli Lilly
Astrazeneca
Johnson & Johnson
Celgene
Novavax
Stryker
Gilead Sciences
OSI Pharmaceuticals
Kadmon Pharmaceuticals
Samyang Biopharm
Mitsubishi Pharma
Kaken Pharmaceutical
Selecta Biosciences
Par Pharmaceutical
Cerulean Pharma
Navidea Biopharmaceuticals
Lummy
Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Nanopharmaceuticals in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Liposomes
Polymeric micelles
Solid lipid nanoparticles
Microemulsion and nanoemulsion
Nanosuspension
Split by application, this report focuses on consumption, market share and growth rate of Nanopharmaceuticals in each application, can be divided into
Application 1
Application 2
Application 3

*** レポート目次(コンテンツ)***

Table of Contents

Global Nanopharmaceuticals Market Research Report 2016
1 Nanopharmaceuticals Market Overview
1.1 Product Overview and Scope of Nanopharmaceuticals
1.2 Nanopharmaceuticals Segment by Type
1.2.1 Global Production Market Share of Nanopharmaceuticals by Type in 2015
1.2.2 Liposomes
1.2.3 Polymeric micelles
1.2.4 Solid lipid nanoparticles
1.2.5 Microemulsion and nanoemulsion
1.2.6 Nanosuspension
1.3 Nanopharmaceuticals Segment by Application
1.3.1 Nanopharmaceuticals Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Nanopharmaceuticals Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Southeast Asia Status and Prospect (2011-2021)
1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Nanopharmaceuticals (2011-2021)

2 Global Nanopharmaceuticals Market Competition by Manufacturers
2.1 Global Nanopharmaceuticals Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 Global Nanopharmaceuticals Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Nanopharmaceuticals Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Nanopharmaceuticals Manufacturing Base Distribution, Sales Area and Product Type
2.5 Nanopharmaceuticals Market Competitive Situation and Trends
2.5.1 Nanopharmaceuticals Market Concentration Rate
2.5.2 Nanopharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Nanopharmaceuticals Capacity, Production, Revenue (Value) by Region (2011-2016)
3.1 Global Nanopharmaceuticals Capacity and Market Share by Region (2011-2016)
3.2 Global Nanopharmaceuticals Production and Market Share by Region (2011-2016)
3.3 Global Nanopharmaceuticals Revenue (Value) and Market Share by Region (2011-2016)
3.4 Global Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.5 North America Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.6 Europe Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.7 China Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Japan Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.9 Southeast Asia Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
3.10 India Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Nanopharmaceuticals Supply (Production), Consumption, Export, Import by Regions (2011-2016)
4.1 Global Nanopharmaceuticals Consumption by Regions (2011-2016)
4.2 North America Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Nanopharmaceuticals Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Nanopharmaceuticals Production, Revenue (Value), Price Trend by Type
5.1 Global Nanopharmaceuticals Production and Market Share by Type (2011-2016)
5.2 Global Nanopharmaceuticals Revenue and Market Share by Type (2011-2016)
5.3 Global Nanopharmaceuticals Price by Type (2011-2016)
5.4 Global Nanopharmaceuticals Production Growth by Type (2011-2016)

6 Global Nanopharmaceuticals Market Analysis by Application
6.1 Global Nanopharmaceuticals Consumption and Market Share by Application (2011-2016)
6.2 Global Nanopharmaceuticals Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Nanopharmaceuticals Manufacturers Profiles/Analysis
7.1 Merck
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Nanopharmaceuticals Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Merck Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Pfizer
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Nanopharmaceuticals Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Pfizer Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Novartis
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Nanopharmaceuticals Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 Novartis Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Abbott
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Nanopharmaceuticals Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Abbott Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 GlaxoSmithKline
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Nanopharmaceuticals Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 GlaxoSmithKline Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Roche
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Nanopharmaceuticals Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Roche Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 Sanofi
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Nanopharmaceuticals Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 Sanofi Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Eli Lilly
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Nanopharmaceuticals Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Eli Lilly Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview
7.9 Astrazeneca
7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
7.9.2 Nanopharmaceuticals Product Type, Application and Specification
7.9.2.1 Type I
7.9.2.2 Type II
7.9.3 Astrazeneca Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9.4 Main Business/Business Overview
7.10 Johnson & Johnson
7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
7.10.2 Nanopharmaceuticals Product Type, Application and Specification
7.10.2.1 Type I
7.10.2.2 Type II
7.10.3 Johnson & Johnson Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10.4 Main Business/Business Overview
7.11 Celgene
7.12 Novavax
7.13 Stryker
7.14 Gilead Sciences
7.15 OSI Pharmaceuticals
7.16 Kadmon Pharmaceuticals
7.17 Samyang Biopharm
7.18 Mitsubishi Pharma
7.19 Kaken Pharmaceutical
7.20 Selecta Biosciences
7.21 Par Pharmaceutical
7.22 Cerulean Pharma
7.23 Navidea Biopharmaceuticals
7.24 Lummy

8 Nanopharmaceuticals Manufacturing Cost Analysis
8.1 Nanopharmaceuticals Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Nanopharmaceuticals

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Nanopharmaceuticals Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Nanopharmaceuticals Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Nanopharmaceuticals Market Forecast (2016-2021)
12.1 Global Nanopharmaceuticals Capacity, Production, Revenue Forecast (2016-2021)
12.2 Global Nanopharmaceuticals Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Nanopharmaceuticals Production Forecast by Type (2016-2021)
12.4 Global Nanopharmaceuticals Consumption Forecast by Application (2016-2021)
12.5 Nanopharmaceuticals Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List of Tables and Figures

Figure Picture of Nanopharmaceuticals
Figure Global Production Market Share of Nanopharmaceuticals by Type in 2015
Figure Product Picture of Liposomes
Table Major Manufacturers of Liposomes
Figure Product Picture of Polymeric micelles
Table Major Manufacturers of Polymeric micelles
Figure Product Picture of Solid lipid nanoparticles
Table Major Manufacturers of Solid lipid nanoparticles
Figure Product Picture of Microemulsion and nanoemulsion
Table Major Manufacturers of Microemulsion and nanoemulsion
Figure Product Picture of Nanosuspension
Table Major Manufacturers of Nanosuspension
Table Nanopharmaceuticals Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Nanopharmaceuticals Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Nanopharmaceuticals Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Nanopharmaceuticals Capacity of Key Manufacturers (2015 and 2016)
Table Global Nanopharmaceuticals Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Nanopharmaceuticals Capacity of Key Manufacturers in 2015
Figure Global Nanopharmaceuticals Capacity of Key Manufacturers in 2016
Table Global Nanopharmaceuticals Production of Key Manufacturers (2015 and 2016)
Table Global Nanopharmaceuticals Production Share by Manufacturers (2015 and 2016)
Figure 2015 Nanopharmaceuticals Production Share by Manufacturers
Figure 2016 Nanopharmaceuticals Production Share by Manufacturers
Table Global Nanopharmaceuticals Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Nanopharmaceuticals Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Nanopharmaceuticals Revenue Share by Manufacturers
Table 2016 Global Nanopharmaceuticals Revenue Share by Manufacturers
Table Global Market Nanopharmaceuticals Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Nanopharmaceuticals Average Price of Key Manufacturers in 2015
Table Manufacturers Nanopharmaceuticals Manufacturing Base Distribution and Sales Area
Table Manufacturers Nanopharmaceuticals Product Type
Figure Nanopharmaceuticals Market Share of Top 3 Manufacturers
Figure Nanopharmaceuticals Market Share of Top 5 Manufacturers
Table Global Nanopharmaceuticals Capacity by Regions (2011-2016)
Figure Global Nanopharmaceuticals Capacity Market Share by Regions (2011-2016)
Figure Global Nanopharmaceuticals Capacity Market Share by Regions (2011-2016)
Figure 2015 Global Nanopharmaceuticals Capacity Market Share by Regions
Table Global Nanopharmaceuticals Production by Regions (2011-2016)
Figure Global Nanopharmaceuticals Production and Market Share by Regions (2011-2016)
Figure Global Nanopharmaceuticals Production Market Share by Regions (2011-2016)
Figure 2015 Global Nanopharmaceuticals Production Market Share by Regions
Table Global Nanopharmaceuticals Revenue by Regions (2011-2016)
Table Global Nanopharmaceuticals Revenue Market Share by Regions (2011-2016)
Table 2015 Global Nanopharmaceuticals Revenue Market Share by Regions
Table Global Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table China Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table India Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Nanopharmaceuticals Consumption Market by Regions (2011-2016)
Table Global Nanopharmaceuticals Consumption Market Share by Regions (2011-2016)
Figure Global Nanopharmaceuticals Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Nanopharmaceuticals Consumption Market Share by Regions
Table North America Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Europe Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table China Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Japan Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table India Nanopharmaceuticals Production, Consumption, Import & Export (2011-2016)
Table Global Nanopharmaceuticals Production by Type (2011-2016)
Table Global Nanopharmaceuticals Production Share by Type (2011-2016)
Figure Production Market Share of Nanopharmaceuticals by Type (2011-2016)
Figure 2015 Production Market Share of Nanopharmaceuticals by Type
Table Global Nanopharmaceuticals Revenue by Type (2011-2016)
Table Global Nanopharmaceuticals Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Nanopharmaceuticals by Type (2011-2016)
Figure 2015 Revenue Market Share of Nanopharmaceuticals by Type
Table Global Nanopharmaceuticals Price by Type (2011-2016)
Figure Global Nanopharmaceuticals Production Growth by Type (2011-2016)
Table Global Nanopharmaceuticals Consumption by Application (2011-2016)
Table Global Nanopharmaceuticals Consumption Market Share by Application (2011-2016)
Figure Global Nanopharmaceuticals Consumption Market Share by Application in 2015
Table Global Nanopharmaceuticals Consumption Growth Rate by Application (2011-2016)
Figure Global Nanopharmaceuticals Consumption Growth Rate by Application (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Nanopharmaceuticals Market Share (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Nanopharmaceuticals Market Share (2011-2016)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novartis Nanopharmaceuticals Market Share (2011-2016)
Table Abbott Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Abbott Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Abbott Nanopharmaceuticals Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Nanopharmaceuticals Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Nanopharmaceuticals Market Share (2011-2016)
Table Sanofi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Sanofi Nanopharmaceuticals Market Share (2011-2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Nanopharmaceuticals Market Share (2011-2016)
Table Astrazeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Astrazeneca Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Astrazeneca Nanopharmaceuticals Market Share (2011-2016)
Table Johnson & Johnson Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Johnson & Johnson Nanopharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Johnson & Johnson Nanopharmaceuticals Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Nanopharmaceuticals
Figure Manufacturing Process Analysis of Nanopharmaceuticals
Figure Nanopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Nanopharmaceuticals Major Manufacturers in 2015
Table Major Buyers of Nanopharmaceuticals
Table Distributors/Traders List
Figure Global Nanopharmaceuticals Capacity, Production and Growth Rate Forecast (2016-2021)
Figure Global Nanopharmaceuticals Revenue and Growth Rate Forecast (2016-2021)
Table Global Nanopharmaceuticals Production Forecast by Regions (2016-2021)
Table Global Nanopharmaceuticals Consumption Forecast by Regions (2016-2021)
Table Global Nanopharmaceuticals Production Forecast by Type (2016-2021)
Table Global Nanopharmaceuticals Consumption Forecast by Application (2016-2021)

















*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(QYR61222954 )"世界のナノ医薬品市場2016" (英文:Global Nanopharmaceuticals Market Research Report 2016)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。